Who Is Mario Capecchi?

Total Page:16

File Type:pdf, Size:1020Kb

Who Is Mario Capecchi? Disease Models & Mechanisms 1, 197-201 (2008) doi:10.1242/dmm.001966 A MODEL FOR LIFE The first transgenic mice: an interview with Mario Capecchi Mario Capecchi recently won the Nobel Prize for contributions to genetics that have catapulted the mouse to the status of the most valuable of all animal models. He has a personal story that is as rich and interesting as his science. Here, he discusses the journey that led him to gene targeting and his vision for the future. The ability to remove or mutate genes to My thought was that the cells were using assess their function has forever changed endocytosis, where cell membranes engulf the fields of biology and medicine. A exogenous material, to internalize the pioneer of this technology, Mario Capecchi DNA. Cells usually do this with the intent was shaped by a unique childhood that of shuttling the internalized material to taught him persistence and self-reliance. He lysosomes to degrade it, and then use what- was born in Italy during World War II. ever is useful to them. So, my thinking was When he was only 4 years old, his American that most of the DNA in those early exper- mother was imprisoned in a German con- iments ended up being degraded and that DMM centration camp and soon after he found very little of it was delivered to the nucleus himself homeless and fending for himself where it could function. I thought that if I on the streets of Italy. After 4 years alone, he made very small hypodermic needles and was reunited with his mother and they stuffed the DNA directly into the nucleus moved to the USA. He quickly developed a itself maybe the efficiency would be much passion for physics and his early work with higher. I did it, and it turned out that effi- James Watson further influenced his scien- ciency was much higher. Now one in every tific mind. His discoveries leading to gene three cells, rather than one in a million cells, targeting are rapidly unlocking the myster- incorporated the gene into its genome in a ies of the mammalian genome. functional form. That was interesting and important, but didn’t answer the question In 2007 you won the Nobel Prize for your of how the DNA was inserted into the role in developing the process of gene genome. targeting, in which homologous recom- Wigler and Axel were using a lot of DNA, bination is used to replace an endoge- and what they did was mix plasmid DNA nous gene with one that has been modi- containing their gene of interest with Disease Models & Mechanisms fied. What inspired you to approach such salmon sperm carrier DNA, which was a monumental challenge? cheap to buy, to get the DNA concentration There was a paper by Wigler and Axel [in high enough to form the precipitate. inserted into the genome in the same ori- Cell, 1977] in which they formed a precip- Because I was injecting individual mole- entation. DNA has an orientation, just like itate of DNA and calcium phosphate on top cules, I could choose to put in 1, 10 or 100 reading a text. If I started by putting all of of cells and found that the cells took up the molecules. When I put the needle into the the separate DNA copies into the nucleus DNA. These cells started out lacking a par- nucleus, the solution that I was injecting and they ended up incorporated into the ticular gene that was necessary for survival had a distinct refractive index so I could genome at a single locus in the same orien- in a chosen medium, but if the cells stably watch the solution spread out in the tation, then this process couldn’t happen incorporated the gene into their genome nucleus. I used that information to measure randomly. then they survived; the efficiency was the volume I was adding to the cells. So, I One possibility is that the cell picks up a roughly one cell in every million. Further, could control how much I was injecting and piece of DNA and uses it as a template, like they showed that the added DNA was ran- then I could also control the concentration a sausage machine, to synthesize more domly incorporated into the host cell of DNA that I was injecting and, conse- copies of the DNA in a process that would genome. quently, how many molecules were being end up producing DNA copies all in the injected. I found that the DNA was ran- same orientation. This would be a synthetic Mario Capecchi is the Distinguished Professor of domly incorporated into the genome, but way of generating the observed head-to-tail Human Genetics and Biology at the University of if I put in 10 copies or 100 copies, or even concatamers. The other possibility was that Utah and an investigator in the Howard Hughes Medical Institute 1000 copies, of the same DNA sequence the DNA copies are put together by ho- (e-mail: [email protected]) into the nucleus, all of the molecules were mologous recombination, a naturally oc- Disease Models & Mechanisms 197 A MODEL FOR LIFE Mario Capecchi curring process in which similar DNA se- The reason that somatic cells use ho- 2007 Nobel Prize.) I asked if I could come to quences on chromosomes can exchange in- mologous recombination is that every day his lab and learn how to work with ES cells formation with each other. Since homolo- each of your cells receives about 10,000 right then and there. He was very generous gous recombination always maintains se- insults to its DNA. The insults arise from to let my wife, Laurie, and I visit his lab. quence orientation, the DNA that has been oxygen radicals produced in the cells, or When I arrived he said to me, “Nobody newly inserted by homologous recombina- from sunlight, or from everything else that’s seems to be interested in my cells” and I told tion would also be in the same orientation. happening to your poor cells. Often, a DNA him, “They will be, just wait!” I could readily distinguish between these strand gets broken. When it breaks, you not two potential models and showed that only lose the gene at the breakage point, but After you developed this new technology head-to-tail concatamers were generated by upon cell division you lose all the genes that there were limitless genetic unknowns homologous recombination. are no longer associated with a centromere. available for study. Why did you choose At that time, people knew about the The first thing a cell wants to do is stick to focus on the HOX gene family? process of homologous those two pieces of It was timing. At that time, Walter Gehring recombination but they DNA back together so in Switzerland had just characterized HOX thought it was primarily I am a very gene-centric that, rather than losing a genes in Drosophila. As Ed Lewis had restricted to myosis (i.e. guy. Not because genes do thousand genes, it just shown, these genes are responsible for spec- during the formation of everything, but because loses one gene. Once ifying segmental identity in Drosophila. sex cells, sperm and that is done, the Walter Gehring and others showed that eggs). When sperm and genes are the easiest place damaged DNA at the these genes contained DNA-binding egg come together you to be able to dissect junction is tagged and domains called homeo boxes. Amazingly, have chromosomes complex biological the cell can use the copy they also showed that HOX genes not only derived from your phenomena with great of the gene from the existed in Drosophila, but also in frogs, DMM mother and father, but other homologous chro- mice and humans. This story was breaking these chromosomes are precision mosome to repair it. For at the same time as we were thinking about not intact chromosomes example, if the maternal which gene to tackle with our technology derived from one maternal or paternal copy is broken, then the paternal copy can for modifying mouse genomes. grandparent. Rather, the chromosomes that be used to repair the damaged gene. This was all happening in the mid-1980s. you received from your mother or father are Homologous recombination is the machin- All of a sudden, these HOX genes were extensive mixtures derived from both of your ery that mediates this repair. Every cell in being characterized at the DNA level and maternal or paternal grandparents, respec- your body has to have very efficient homol- identified in many species. Up until then, tively. The extensive exchanges between the ogous DNA repair machinery or it could people knew that, for example, the citric pairs of chromosomes derived from your not survive. acid cycle was going to be the same in all grandparents are mediated by homologous Since the machinery is there in every cell species from plants to humans, so they recombination. This process generates I asked, ‘how can we fool Mother Nature to thought of metabolism as being conserved, much, much greater variation in the DNA use this machinery for our advantage?’ but they didn’t think that the genetic cir- content that is present in each of your chil- What if I could convince the homologous cuitry responsible for development would dren than if your sperm or egg contained recombination machinery that I’m present- be the same among disparate species. The intact copies of chromosomes obtained from ing the ‘good copy’ of the gene to the cell, conservation of HOX genes among many Disease Models & Mechanisms one grandparent or the other.
Recommended publications
  • Unrestricted Immigration and the Foreign Dominance Of
    Unrestricted Immigration and the Foreign Dominance of United States Nobel Prize Winners in Science: Irrefutable Data and Exemplary Family Narratives—Backup Data and Information Andrew A. Beveridge, Queens and Graduate Center CUNY and Social Explorer, Inc. Lynn Caporale, Strategic Scientific Advisor and Author The following slides were presented at the recent meeting of the American Association for the Advancement of Science. This project and paper is an outgrowth of that session, and will combine qualitative data on Nobel Prize Winners family histories along with analyses of the pattern of Nobel Winners. The first set of slides show some of the patterns so far found, and will be augmented for the formal paper. The second set of slides shows some examples of the Nobel families. The authors a developing a systematic data base of Nobel Winners (mainly US), their careers and their family histories. This turned out to be much more challenging than expected, since many winners do not emphasize their family origins in their own biographies or autobiographies or other commentary. Dr. Caporale has reached out to some laureates or their families to elicit that information. We plan to systematically compare the laureates to the population in the US at large, including immigrants and non‐immigrants at various periods. Outline of Presentation • A preliminary examination of the 609 Nobel Prize Winners, 291 of whom were at an American Institution when they received the Nobel in physics, chemistry or physiology and medicine • Will look at patterns of
    [Show full text]
  • MED C-LIVE Transcript
    JUNE 2020 Mario Capecchi, Ph.D. NOT FOR PUBLIC DISTRIBUTION Michael Keel My name is Michael Keel from New Jersey. And it is my honor to introduce Dr. Mario Capecchi. Dr. Capecchi is the Distinguished Professor of Human Genetics at the University of Utah School of Medicine. He is best known for his groundbreaking work in gene targeting, in mass embryo derived stem cells. He was awarded the Nobel Prize in Physiology for Medicine, for his work in finding ways to manipulate the mammalian genome by changing mammals’ genes. His research interests include analysis of neural development in mammals, gene therapy, and production of murine models of human genetic diseases, from cancer to neuropsychiatric disorders. Dr. Capecchi, welcome to the Congress of Future Medical Leaders. Dr. Capecchi Thank you. First of all, welcome to the Medical Leaders’ Congress. It's a pleasure to be here. My name is Mario. I'm going to be talking about gene targeting. Next slide please. My laboratory has developed a technology called gene targeting that allows you to change any gene in any conceivable manner in a living creature, such as a mouse. Next slide. Why do we do gene targeting? Next slide. There are many reasons, but they boil down to two. One is basic research and the other is applied research. In basic research, you investigate the biology of an animal. For example, how do you make a limb or a heart or a brain? Those are basic research questions. The other is applied research. That is we can use gene targeting to generate mice with human diseases.
    [Show full text]
  • Discovery of DNA Structure and Function: Watson and Crick By: Leslie A
    01/08/2018 Discovery of DNA Double Helix: Watson and Crick | Learn Science at Scitable NUCLEIC ACID STRUCTURE AND FUNCTION | Lead Editor: Bob Moss Discovery of DNA Structure and Function: Watson and Crick By: Leslie A. Pray, Ph.D. © 2008 Nature Education Citation: Pray, L. (2008) Discovery of DNA structure and function: Watson and Crick. Nature Education 1(1):100 The landmark ideas of Watson and Crick relied heavily on the work of other scientists. What did the duo actually discover? Aa Aa Aa Many people believe that American biologist James Watson and English physicist Francis Crick discovered DNA in the 1950s. In reality, this is not the case. Rather, DNA was first identified in the late 1860s by Swiss chemist Friedrich Miescher. Then, in the decades following Miescher's discovery, other scientists--notably, Phoebus Levene and Erwin Chargaff--carried out a series of research efforts that revealed additional details about the DNA molecule, including its primary chemical components and the ways in which they joined with one another. Without the scientific foundation provided by these pioneers, Watson and Crick may never have reached their groundbreaking conclusion of 1953: that the DNA molecule exists in the form of a three-dimensional double helix. The First Piece of the Puzzle: Miescher Discovers DNA Although few people realize it, 1869 was a landmark year in genetic research, because it was the year in which Swiss physiological chemist Friedrich Miescher first identified what he called "nuclein" inside the nuclei of human white blood cells. (The term "nuclein" was later changed to "nucleic acid" and eventually to "deoxyribonucleic acid," or "DNA.") Miescher's plan was to isolate and characterize not the nuclein (which nobody at that time realized existed) but instead the protein components of leukocytes (white blood cells).
    [Show full text]
  • Strategies and Experiences to Improve Research Uptake: the Royal Society and UK Science Funding
    Strategies and experiences to improve research uptake: The Royal Society and UK science funding Wider context Credit crunch UK Government Deficit New government Spending cuts The Royal Society Advisory Group Sir Martin Taylor FRS (Chair), Former Vice-President and Physical Secretary, The Royal Society Professor Glynis Breakwell, Vice-Chancellor, University of Bath Professor Ann Dowling DBE CBE FRS FREng, Professor of Engineering, University of Cambridge Sir Martin Evans FRS, Director, Cardiff School of Biosciences Sir Richard Friend FRS. Professor of Physics, University of Cambridge Professor Rachel Griffith FBA, Deputy Research Director, Institute for Fiscal Studies Professor Wendy Hall DBE FREng FRS, Professor of Computer Science, University of Southampton Dr Emily Holmes, Department of Psychiatry, University of Oxford Professor Richard Jones FRS, Professor of Physics, Sheffield University Professor Ben Martin, Science and Technology Policy Research Unit (SPRU) Paul Mountford, President, Emerging Markets, Cisco Professor Helga Nowotny, Vice-President, European Research Council Sir Paul Nurse FRS, President, Rockefeller University, New York City Dr David Roblin, Vice-President Global R&D, Pfizer Lord Sainsbury of Turville FRS, Gatsby Charitable Foundation Lord Waldegrave of North Hill, Provost, Eton College Sir Mark Walport, Director of the Wellcome Trust Sir Alan Wilson FRS FBA, Chairman, Arts and Humanities Research Council 7 Engagement across the political spectrum Lord Sainsbury of Turville FRS, Lord Waldegrave of North Hill, Conservative Labour Public R&D expenditure, 1970-2007 The UK punches above its weight The Cambridge phenomenon People in and outside science Global competition Average annual growth in R&D budgets, 1997-2007 ‘By the end of 2020…China will join the ranks of the world’s most innovative countries’ President Hu Jintao, Jan 2006 Investing in the downturn 0.60% 0.50% 0.40% Green technology R&D 0.30% GDP 0.20% 0.10% 0.00% Finland Norway Canada Portugal Germany Sweden USA Recommendations 1.
    [Show full text]
  • Biochemistry, Genetics, Molecular and Cell Biology) Hit the Newspaper Headlines on a Weekly Basis
    The Tenovus-Scotland Symposia and Medal Lectures Today medical advances as a result of discoveries in the Life Sciences (Biochemistry, Genetics, Molecular and Cell Biology) hit the newspaper headlines on a weekly basis. This was not the case at the time of the first Tenovus-Scotland Symposium nearly 35 years ago. Since the discovery of the structure of DNA twenty years earlier, great advances had been made in understanding, at the level of molecules, how genes work in the cell. From study of simple bacteria and viruses, it was known that the information for making all the different proteins in the cell was encoded in the sequence of nucleotides, the individual chemical units of DNA, but study of higher organisms seemed impossibly complex. The chromosomes in each human cell have about 23,000 genes in their DNA that contains a total of about three thousand million nucleotides - how would it be possible to study these genes individually? Three staff from the Biochemistry Department and the Beatson Institute planned a two day meeting at Glasgow University in 1974 to bring together scientists to discuss and learn about the new discoveries that were beginning to provide answers to that fundamental question. Sir Charles Illingworth, who had recently founded Tenovus- Scotland, saw the importance of these studies and their potential future application in medicine and agreed a grant towards the cost of the meeting, which we called the Tenovus-Scotland Symposium although the First Meeting was also jointly sponsored by the Nucleotide Group of the
    [Show full text]
  • 2004 Albert Lasker Nomination Form
    albert and mary lasker foundation 110 East 42nd Street Suite 1300 New York, ny 10017 November 3, 2003 tel 212 286-0222 fax 212 286-0924 Greetings: www.laskerfoundation.org james w. fordyce On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination Chairman neen hunt, ed.d. for the 2004 Albert Lasker Medical Research Awards. President mrs. anne b. fordyce The Awards will be offered in three categories: Basic Medical Research, Clinical Medical Vice President Research, and Special Achievement in Medical Science. This is the 59th year of these christopher w. brody Treasurer awards. Since the program was first established in 1944, 68 Lasker Laureates have later w. michael brown Secretary won Nobel Prizes. Additional information on previous Lasker Laureates can be found jordan u. gutterman, m.d. online at our web site http://www.laskerfoundation.org. Representative Albert Lasker Medical Research Awards Program Nominations that have been made in previous years may be updated and resubmitted in purnell w. choppin, m.d. accordance with the instructions on page 2 of this nomination booklet. daniel e. koshland, jr., ph.d. mrs. william mccormick blair, jr. the honorable mark o. hatfied Nominations should be received by the Foundation no later than February 2, 2004. Directors Emeritus A distinguished panel of jurors will select the scientists to be honored. The 2004 Albert Lasker Medical Research Awards will be presented at a luncheon ceremony given by the Foundation in New York City on Friday, October 1, 2004. Sincerely, Joseph L. Goldstein, M.D. Chairman, Awards Jury Albert Lasker Medical Research Awards ALBERT LASKER MEDICAL2004 RESEARCH AWARDS PURPOSE AND DESCRIPTION OF THE AWARDS The major purpose of these Awards is to recognize and honor individuals who have made signifi- cant contributions in basic or clinical research in diseases that are the main cause of death and disability.
    [Show full text]
  • Eighty Years of Fighting Against Cancer in Serbia Ovarian Cancer Vaccine
    News Eighty years of fighting against cancer Recent study by Kunle Odunsi et al., Roswell Park Cancer Institute, Buffalo, in Serbia New York, USA, showed an effects of vaccine based on NY-ESO-1, a „cancer This year on December 10th, Serbian society for the fight against cancer has testis“ antigen in preventing the recurrence of ovarian cancer. NY-ESO-1 is a ovarian celebrated the great jubilee - 80 years of its foundation. The celebration took „cancer-testis“ antigen expressed in epithelial cancer (EOC) and is place in Crystal Room of Belgrade’s Hyatt hotel, gathering many distinguished among the most immunogenic tumor antigens defined to date. presence + guests from the country and abroad. This remarkable event has been held Author’s previous study point to the role of of intraepithelial CD8 - under the auspices of the President of Republic of Serbia, Mr. Boris Tadić. infiltrating T lymphocytes in tumors that was associated with improved survival of The whole ceremony was presided by Prof. Dr. Slobodan Čikarić, actual presi- patients with the disease. The NY-ESO-1 peptide epitope, ESO157–170, is recog- + + dent of Society, who greeted guests and wished them a warm welcome. Than nized by HLA-DP4-restricted CD4 T cells and HLA-A2- and A24-restricted CD8 + followed the speech of Serbian health minister, Prof. Dr. Tomica Milosavljević T cells. To test whether providing cognate helper CD4 T cells would enhance who pointed out the importance of preventive measures and public education the antitumor immune response, Odunsi et al., conducted a phase I clinical trial along with timely diagnosis and multidisciplinary treatment in global fight of immunization with ESO157–170 mixed with incomplete Freund's adjuvant + against cancer in Serbia.
    [Show full text]
  • I. Hox Genes 2
    School ofMedicine Oregon Health Sciences University CERTIFICATE OF APPROVAL This is certify that the Ph.D. thesis of WendyKnosp has been approved Mentor/ Advisor ~ Member Member QUANTITATIVE ANALYSIS OF HOXA13 FUNCTION IN THE DEVELOPING LIMB By Wendy M. lt<nosp A DISSERTATION Presented to the Department of Molecular and Medical Genetics and the Oregon Health & Science University School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy August 2006 TABLE OF CONTENTS LIST OF FIGURES iv LIST OF ABBREVIATIONS vii ACKNOWLEDGEMENTS X ABSTRACT xii CHAPTER 1: Introduction 1 I. Hox genes 2 A. Discovery of Hox genes in Drosophila melanogaster 2 B. Hox cluster colinearity and conservation 7 C. Human Hox mutations 9 D. Hoxa13: HFGS and Guttmacher syndromes 10 II. The Homeodomain 12 A. Homeodomain structure 12 B. DNA binding 14 Ill. Limb development 16 A. Patterning of the limb axes 16 B. Digit formation 20 C. lnterdigital programmed cell death 21 IV. BMPs and limb development 23 A. BMP signaling in the limb 23 B. BMP target genes 27 V. Hoxa13 and embryonic development 30 A. The Hoxa13-GFP mouse model 30 B. Hoxa13 mutant phenotypes 34 C. HOXA 13 homeodomain 35 D. HOXA 13 protein-protein interactions 36 E. HOXA 13 target genes 37 VI. Hypothesis and Rationale 39 CHAPTER 2: HOXA13 regulates Bmp2 and Bmp7 40 I. Abstract 42 II. Introduction 43 Ill. Results 46 IV. Discussion 69 v. Materials and Methods 75 VI. Acknowledgements 83 11 CHAPTER 3: Quantitative analysis of HOXA13 function 84 HOXA 13 regulation of Sostdc1 I.
    [Show full text]
  • October 2, 2001, NIH Record, Vol. LIII, No. 20
    R Still The Second Best Thing About Payday Translating the Histone Code: A H G H L 1,G H T, S Tale of Tails at Stetten Talk Attacks on U.S. Change Life at NIH By Rich McManus By Alison Davis Security Beefed Up News stories appearing over the last year he transition from peacetime's reliable routine to wartime On Campus would have everyone believe that scientists anxiety took place in only minutes as NTH employees came have-once and for all~racked the human Tto work on an otherwise spectacular late summer morning genetic code. Indeed, two teams of 50th Anniversary Sept. 11 and scientists have already published a draft For NINOS, NIMH discovered by 9:45- sequence of our 3-billion-unit jumble of via office televisions, DNA "letters." But t he task of thoroughly radio, the web, deciphering the code's protein-making phone calls and Grantees Win hallway conversa­ instructions-something our bodies do Lasker Award SEE STETTEN LECTURE, PAGE 2 tions-that terror­ ism on an almost unimaginable scale Kolb To Give was taking place in Pittman Lecture New York City and in the heart of Washington, D.C. Fall Computer The workday froze Courses Offered as workers tuned in to the news-the World Trade Center towers in flames, Flag flies at half-mast in tragedy's wake. Outdoor Film and smoke rising from behind the Old Executive Office buiJding Dr. C. David Allis to give Stetten Lecture. Festival a Big Hit near the White House. Summer Jobs into Permanent Posts In the OD Office of Communications and Public Liaison in Bldg.
    [Show full text]
  • Jewels in the Crown
    Jewels in the crown CSHL’s 8 Nobel laureates Eight scientists who have worked at Cold Max Delbrück and Salvador Luria Spring Harbor Laboratory over its first 125 years have earned the ultimate Beginning in 1941, two scientists, both refugees of European honor, the Nobel Prize for Physiology fascism, began spending their summers doing research at Cold or Medicine. Some have been full- Spring Harbor. In this idyllic setting, the pair—who had full-time time faculty members; others came appointments elsewhere—explored the deep mystery of genetics to the Lab to do summer research by exploiting the simplicity of tiny viruses called bacteriophages, or a postdoctoral fellowship. Two, or phages, which infect bacteria. Max Delbrück and Salvador who performed experiments at Luria, original protagonists in what came to be called the Phage the Lab as part of the historic Group, were at the center of a movement whose members made Phage Group, later served as seminal discoveries that launched the revolutionary field of mo- Directors. lecular genetics. Their distinctive math- and physics-oriented ap- Peter Tarr proach to biology, partly a reflection of Delbrück’s physics train- ing, was propagated far and wide via the famous Phage Course that Delbrück first taught in 1945. The famous Luria-Delbrück experiment of 1943 showed that genetic mutations occur ran- domly in bacteria, not necessarily in response to selection. The pair also showed that resistance was a heritable trait in the tiny organisms. Delbrück and Luria, along with Alfred Hershey, were awarded a Nobel Prize in 1969 “for their discoveries concerning the replication mechanism and the genetic structure of viruses.” Barbara McClintock Alfred Hershey Today we know that “jumping genes”—transposable elements (TEs)—are littered everywhere, like so much Alfred Hershey first came to Cold Spring Harbor to participate in Phage Group wreckage, in the chromosomes of every organism.
    [Show full text]
  • Michael S. Brown, MD
    DISTINGUISHED PHYSICIANS AND Michael S. Brown, M.D. Sir Richard Roberts, Ph.D. Winner, 1985 Nobel Prize in Physiology or Medicine Winner, 1993 Nobel Prize in Physiology or Medicine MEDICAL SCIENTISTS MENTORING Winner, 1988 Presidential National Medal of Science A globally prominent biochemist and molecular biologist, DELEGATES HAVE INCLUDED... Dr. Brown received the world’s most prestigious medical Dr. Roberts was awarded the Nobel Prize for his prize for his work describing the regulation of the groundbreaking contribution to discovering RNA splicing. cholesterol metabolism. His work laid the foundation for Dr. Roberts is dedicating his future research to GMO crops the class of drugs now called statins taken daily by more than 20 million and food sources, and demonstrating the effect they have on humanity. — GRANDg MASTERS — people worldwide. Ferid Murad, M.D., Ph.D. Mario Capecchi, Ph.D. Boris D. Lushniak, M.D., M.P.H Winner, 1998 Nobel Prize in Physiology or Medicine Academy Science Director The Surgeon General of the United States (acting, 2013-2014) Winner, 2007 Nobel Prize in Physiology or Medicine A world-renowned pioneer in biochemistry, Dr. Murad’s Winner, 2001 National Medal of Science Rear Admiral Lushniak, M.D., M.P.H., was the United award-winning research demonstrated that nitroglycerin Winner, 2001 Lasker Award States’ leading spokesperson on matters of public health, and related drugs help patients with heart conditions by Winner, 2003 Wolf Prize in Medicine overseeing the operations of the U.S. Public Health Service releasing nitric oxide into the body, thus relaxing smooth Mario Capecchi, Ph.D., a biophysicist, is a Distinguished Commissioned Corps, which consists of approximately muscles by elevating intracellular cyclic GMP, leading to vasodilation and Professor of Human Genetics at the University of Utah School of Medicine.
    [Show full text]
  • MCDB 5220 Methods and Logics April 21 2015 Marcelo Bassalo
    Cracking the Genetic Code MCDB 5220 Methods and Logics April 21 2015 Marcelo Bassalo The DNA Saga… so far Important contributions for cracking the genetic code: • The “transforming principle” (1928) Frederick Griffith The DNA Saga… so far Important contributions for cracking the genetic code: • The “transforming principle” (1928) • The nature of the transforming principle: DNA (1944 - 1952) Oswald Avery Alfred Hershey Martha Chase The DNA Saga… so far Important contributions for cracking the genetic code: • The “transforming principle” (1928) • The nature of the transforming principle: DNA (1944 - 1952) • X-ray diffraction and the structure of proteins (1951) Linus Carl Pauling The DNA Saga… so far Important contributions for cracking the genetic code: • The “transforming principle” (1928) • The nature of the transforming principle: DNA (1944 - 1952) • X-ray diffraction and the structure of proteins (1951) • The structure of DNA (1953) James Watson and Francis Crick The DNA Saga… so far Important contributions for cracking the genetic code: • The “transforming principle” (1928) • The nature of the transforming principle: DNA (1944 - 1952) • X-ray diffraction and the structure of proteins (1951) • The structure of DNA (1953) How is DNA (4 nucleotides) the genetic material while proteins (20 amino acids) are the building blocks? ? DNA Protein ? The Coding Craze ? DNA Protein What was already known? • DNA resides inside the nucleus - DNA is not the carrier • Protein synthesis occur in the cytoplasm through ribosomes {• Only RNA is associated with ribosomes (no DNA) - rRNA is not the carrier { • Ribosomal RNA (rRNA) was a homogeneous population The “messenger RNA” hypothesis François Jacob Jacques Monod The Coding Craze ? DNA RNA Protein RNA Tie Club Table from Wikipedia The Coding Craze Who won the race Marshall Nirenberg J.
    [Show full text]